Barely Significant
← all excerpts

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients.

J Immunother Cancer · 2015 · PMC4647471 · PMID 26579227

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
Due to small sample size (a cohort of 29 patients) and variable preliminary nature of the patients, some of our analyses only showed a trend of increase or decrease, but did not turn out to be statistically significant.

also in 53,322 other papers

On the contrary, 7 of the 10 responders had decreased levels of monoctyic MDSC in the peripheral circulation post-cetuximab, but this finding did not reach statistical significance (Fig. 1b and c ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.